
In advance of the Anti-Doping and Medication Control (ADMC) Program effective date of March 27, 2023, HISA has received requests for clarification of Rule 4222. Please read below.
Rule 4222 (M5 Intra-Articular Injections) reads:
Intra-articular injections are prohibited on Race Day, within 14 days prior to Post-Time, and within 7 days prior to any Timed and Reported Workout.
The prohibitions in Rule 4222 apply to substances injected into any articular space, including, but not limited to, the following:
*Note that Rule 4224, “M7 Intra-articular injections of polyacrylamide hydrogels,” states: “Intra-articular injections of polyacrylamide hydrogels are prohibited within 180 days prior to Post-Time.”
The intra-articular administration of any Banned Substance, such as stanozolol, constitutes an Anti-Doping Rule Violation.
These stand-down times do NOT apply to injections in or around the following structures:
Injections in or around these structures will be regulated through testing under HISA’s Anti-Doping and Medication Control Program. For many of these administrations, a withdrawal interval greater than 14 days may be necessary to avoid detection in a treated horse’s collected sample.
ATTENDING VETERINARIANS: PLEASE NOTE that intra-articular administrations MUST be reported to HISA in an electronic format approved by HISA.
A NOTE WITH REGARD TO TIMING:
The day of administration is considered day 1 (one). A horse may breeze on day 8 (eight) following administration and may enter to race at any time, provided the race is on day 15 (fifteen) or later.